Latest News

Business of Cannabis

The House sponsor of the Secure and Fair Enforcement (SAFE) Banking Act, Rep. Ed Perlmutter, says he recently spoke with Senate Majority Leader Chuck Schumer (D-NY) at an event at the White House and discussed the need to enact the bipartisan reform this session.

The lack of banking services for cannabis businesses means many have to deal in large quantities of cash which has caused problems such as robberies.

Benzinga

Impact of Possible German Cannabis Legalization
If Germany legalizes adult use, a wave of benefits could come to the nation, Europe and plant research.

“The European cannabis industry will light up like a wild bush fire once Germany lays out the rules,” predicts Michael Sassano, CEO of Somai Pharmaceuticals.

He predicts “a mad rush” of countries following in Germany’s footsteps. “Germany legalizing is a big leading indicator for all of Europe to follow suit.”

Sifted

Walking around Europe’s largest cannabis manufacturing facility, it quickly becomes obvious that I’m in the hands of a veteran. Even though we’re surrounded by millions of euros’ worth of state-of-the-art machinery, Somai Pharmaceuticals’ founder and CEO Michael Sassano is more concerned with the tiny scuffs he’s noticing on the walls and floor than the impressive technology.

Maximum Yield

Article by Anthony Demeo and Michael Sassano
The global market is waking up to quality concentrates and extracts, but it’s still the U.S. that leads the way thanks to superior cannabis genetics.
Concentrates may have been first created on the west coast of the United States, but the global cannabis market at large is starting to awaken to the purity, tastes, and benefits of dabbing and concentrate consumption. Concentrates make up nearly 10 percent of total cannabis sales in the U.S. and since Canada legalized cannabis 2.0, sales of concentrates are steadily growing and are expected to surpass the current 2.9 percent market share to be in line with U.S. percentage sales within the next three years. Even South America is seeing the early concentrate entrants and it is only a matter of time before Europe and others develop legal frameworks for manufacturers to offer this significant sector of cannabis products.

Cannabis Law Journal

Consistent and reliable pharmaceutical manufacturing depends on many factors, but a critical one is the process equipment. If the process equipment is faulty, the product quality may be at risk, and downtime may be inevitable. This can lead to product contamination and safety risk. Additionally, faulty equipment will impact the production costs, so you must ensure the process equipment is well maintained. Well-run equipment will reduce the time to produce a batch, reduce stops during manufacturing and even eliminate long stops for extreme repairs. The target of maintenance is to run the process equipment at maximum use, avoid unpredictable stops and/or decrease maintenance costs.